Has Shinichi Fukuhara, MD received payments from drug or device companies?

Yes. Drug and device makers reported $236,277 in general payments to Shinichi Fukuhara, MD across 440 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shinichi Fukuhara, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shinichi Fukuhara, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shinichi Fukuhara, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Ann Arbor, MINPI 1659682797

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Artivion, Inc. at 38.1% of the total. 2025 is the largest year on record at $142,965, more than ten times the $7,686 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$236,277in general payments, 2019–2025

Across 440 payments — averaging $536.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Artivion, Inc.$90K
Medtronic$80K
Edwards Lifesciences$43K
Bolton Medical Inc$15K
W. L. Gore & Associates, Inc.$4K
Cerus Corporation$1K
plus $2K from 7 others

$665,003in research payments, 2019–2025

Across 123 payments — averaging $5406.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Artivion, Inc.$277K
Medtronic$235K
Abbott$82K
Bolton Medical Inc$72K

What the payments were for

Consulting fees$110,92247%
Speaking & faculty fees$65,46928%
Travel & lodging$40,56917%
Food & beverage$19,3188%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Artivion, Inc.	92	$90,124
Medtronic(2 entities)	177	$80,434
Edwards Lifesciences	92	$43,103
Bolton Medical Inc	36	$15,245
W. L. Gore & Associates, Inc.	25	$4,209
Cerus Corporation	2	$1,413
Pinnacle, Inc	4	$595
Arthrex	4	$406
Corcym Inc	1	$215
Baxter Healthcare	4	$203
Abbott	1	$164
Boston Scientific	1	$154
Livanova USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AMDS-Ascyrus Medical$57,753
COREVALVE EVOLUT R$38,341
Avalus$25,689
Cardiac non-SynerGraft$10,047
Valiant Captivia$8,400
ARCEVO LSA$7,200
TREO ABDOMINAL STENT-GRAFT SYSTEM$5,883
Relay Plus$5,649
E-vita OPEN NEO$4,800
INSPIRIS RESILIA aortic valve$4,578
Product in Development$2,443
Relay Grafts$2,000
CRYOVALVE SG PULMONARY HUMAN HEART VALVE$2,000
ENDURANT IIS$1,790
INTERCEPT BLOOD SYSTEM FOR PLATELETS$1,413
MITRIS RESILIA Mitral Valve$1,329
GORE TAG Thoracic Endoprosthesis$1,294
KONECT RESILIA$605
Jotec Products$466
EDWARDS INTUITY Elite valve system$401

How this compares

$236,277 in reported general payments places this provider in the 95th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan →

Medicare billing

Part B allowed, 2024

$312,785

Medicare patients

144

Services billed

353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Chloride	12	$150
Amiodarone Hcl	11	$129
Metoprolol Succinate	12	$91
Metoprolol Tartrate	14	$58
Amoxicillin	58	$41
Furosemide	12	$26

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Ann Arbor

Steven BollingAnn Arbor$41.7M
Gorav AilawadiAnn Arbor$434K
Bo YangAnn Arbor$180K
Matthew RomanoAnn Arbor$177K
Chigozirim EkekeAnn Arbor$92K
Himanshu PatelAnn Arbor$58K
Rishindra ReddyAnn Arbor$58K
Barbara HamiltonAnn Arbor$34K
Kenneth HasslerAnn Arbor$31K
Tessa WattAnn Arbor$22K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →